Capital International Investors Sells 505,624 Shares of Mineralys Therapeutics, Inc. $MLYS

Capital International Investors decreased its holdings in Mineralys Therapeutics, Inc. (NASDAQ: MLYS) by 17.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,393,396 shares of the company's stock after selling 505,624 shares during the period. Capital International Investors owned